Sarepta Therapeutics | SRPT - Ordinary Share Capital


Sarepta Therapeutics reported $104.77M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 168.71M 104K Sep/2025
Agios Pharmaceuticals USD 58.28M 241K Sep/2025
Alnylam Pharmaceuticals USD 131.79M 130.49M Sep/2025
Amgen USD 538M 300K Sep/2025
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 192.1M 97K Sep/2025
Daiichi Sankyo JPY 1.85B 9K Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Gilead Sciences USD 1.24B 0 Sep/2025
Incyte USD 196.13M 2.01M Sep/2025
Insmed USD 212.58M 210.76M Sep/2025
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
Moderna USD 391M 2M Sep/2025
Neurocrine Biosciences USD 99.7M 700K Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
PTC Therapeutics USD 79.93M 554K Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Sarepta Therapeutics USD 104.77M 7.06M Sep/2025
Tectonic Therapeutic USD 14.86M 111.83K Dec/2024
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
Vertex Pharmaceuticals USD 254M 2.29M Sep/2025